Loading...

China Resources Medical Holdings

DB:1PH
Snowflake Description

Flawless balance sheet and fair value.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
1PH
DB
HK$7B
Market Cap
  1. Home
  2. DE
  3. Healthcare
Company description

China Resources Medical Holdings Company Limited, an investment holding company, provides general healthcare, and hospital management and consulting services in the People’s Republic of China. The last earnings update was 23 days ago. More info.


Add to Portfolio Compare Print
1PH Share Price and Events
7 Day Returns
3.3%
DB:1PH
-3.3%
DE Healthcare
-0.2%
DE Market
1 Year Returns
-41.4%
DB:1PH
-24.7%
DE Healthcare
-10.3%
DE Market
1PH Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
China Resources Medical Holdings (1PH) 3.3% -5.2% 2.8% -41.4% -47.8% -36.8%
DE Healthcare -3.3% -0.7% 2.9% -24.7% -17.1% 37.8%
DE Market -0.2% -2.4% 4.2% -10.3% 11.2% 10.8%
1 Year Return vs Industry and Market
  • 1PH underperformed the Healthcare industry which returned -24.7% over the past year.
  • 1PH underperformed the Market in Germany which returned -10.3% over the past year.
Price Volatility
1PH
Industry
5yr Volatility vs Market

Value

 Is China Resources Medical Holdings undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of China Resources Medical Holdings to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for China Resources Medical Holdings.

DB:1PH Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 7 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 5.1%
Perpetual Growth Rate 10-Year DE Government Bond Rate 0.2%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for DB:1PH
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year DE Govt Bond Rate 0.2%
Equity Risk Premium S&P Global 6%
Healthcare Unlevered Beta Simply Wall St/ S&P Global 0.68
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.684 (1 + (1- 25%) (8.38%))
0.817
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.82
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 0.23% + (0.817 * 5.96%)
5.1%

Discounted Cash Flow Calculation for DB:1PH using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for China Resources Medical Holdings is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

DB:1PH DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (CNY, Millions) Source Present Value
Discounted (@ 5.1%)
2019 642.13 Analyst x2 610.99
2020 503.08 Analyst x2 455.47
2021 430.42 Analyst x1 370.79
2022 383.78 Est @ -10.84% 314.58
2023 354.93 Est @ -7.52% 276.82
2024 336.50 Est @ -5.19% 249.72
2025 324.49 Est @ -3.57% 229.13
2026 316.61 Est @ -2.43% 212.73
2027 311.45 Est @ -1.63% 199.11
2028 308.10 Est @ -1.07% 187.42
Present value of next 10 years cash flows CN¥3,106.75
DB:1PH DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2028 × (1 + g) ÷ (Discount Rate – g)
= CN¥308.10 × (1 + 0.23%) ÷ (5.1% – 0.23%)
CN¥6,342.91
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= CN¥6,342.91 ÷ (1 + 5.1%)10
CN¥3,858.38
DB:1PH Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= CN¥3,106.75 + CN¥3,858.38
CN¥6,965.13
Equity Value per Share
(CNY)
= Total value / Shares Outstanding
= CN¥6,965.13 / 1,296.68
CN¥47.44
DB:1PH Discount to Share Price
Calculation Result
Exchange Rate CNY/HKD
(Reporting currency to currency of SEHK:1515)
1.135
Value per Share
(HKD)
= Value per Share in CNY x Exchange Rate (CNY/HKD)
= CN¥5.37 x 1.135
HK$6.1
Non-primary Listing Adjustment Factor 1 share in DB:1PH represents 0.11324x of SEHK:1515
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.11324x
Value per Share
(Listing Adjusted, EUR)
= Value per Share (HKD) x Listing Adjustment Factor
= HK$ 6.10 x 0.11324
€0.69
Value per share (EUR) From above. €0.69
Current discount Discount to share price of €0.63
= -1 x (€0.63 - €0.69) / €0.69
8.3%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price China Resources Medical Holdings is available for.
Intrinsic value
8%
Share price is €0.633 vs Future cash flow value of €0.69022
Current Discount Checks
For China Resources Medical Holdings to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • China Resources Medical Holdings's share price is below the future cash flow value, but not at a moderate discount (< 20%).
  • China Resources Medical Holdings's share price is below the future cash flow value, but not at a substantial discount (< 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for China Resources Medical Holdings's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are China Resources Medical Holdings's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
DB:1PH PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in CNY CN¥0.34
SEHK:1515 Share Price ** SEHK (2019-05-17) in HKD HK$5.59
SEHK:1515 Share Price converted to CNY reporting currency Exchange rate (HKD/ CNY) 0.881 CN¥4.93
Germany Healthcare Industry PE Ratio Median Figure of 10 Publicly-Listed Healthcare Companies 36.92x
Germany Market PE Ratio Median Figure of 424 Publicly-Listed Companies 20.17x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of China Resources Medical Holdings.

DB:1PH PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= SEHK:1515 Share Price ÷ EPS (both in CNY)

= 4.93 ÷ 0.34

14.49x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • China Resources Medical Holdings is good value based on earnings compared to the DE Healthcare industry average.
  • China Resources Medical Holdings is good value based on earnings compared to the Germany market.
Price based on expected Growth
Does China Resources Medical Holdings's expected growth come at a high price?
Raw Data
DB:1PH PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 14.49x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 7 Analysts
3.5%per year
Germany Healthcare Industry PEG Ratio Median Figure of 7 Publicly-Listed Healthcare Companies 1.4x
Germany Market PEG Ratio Median Figure of 273 Publicly-Listed Companies 1.53x

*Line of best fit is calculated by linear regression .

DB:1PH PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 14.49x ÷ 3.5%

4.18x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • China Resources Medical Holdings is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on China Resources Medical Holdings's assets?
Raw Data
DB:1PH PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in CNY CN¥4.45
SEHK:1515 Share Price * SEHK (2019-05-17) in HKD HK$5.59
SEHK:1515 Share Price converted to CNY reporting currency Exchange rate (HKD/ CNY) 0.881 CN¥4.93
Germany Healthcare Industry PB Ratio Median Figure of 11 Publicly-Listed Healthcare Companies 1.51x
Germany Market PB Ratio Median Figure of 576 Publicly-Listed Companies 1.77x
DB:1PH PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= SEHK:1515 Share Price ÷ Book Value per Share (both in CNY)

= 4.93 ÷ 4.45

1.11x

* Primary Listing of China Resources Medical Holdings.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • China Resources Medical Holdings is good value based on assets compared to the DE Healthcare industry average.
X
Value checks
We assess China Resources Medical Holdings's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare industry average (and greater than 0)? (1 check)
  5. China Resources Medical Holdings has a total score of 3/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is China Resources Medical Holdings expected to perform in the next 1 to 3 years based on estimates from 7 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
3.5%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is China Resources Medical Holdings expected to grow at an attractive rate?
  • China Resources Medical Holdings's earnings growth is expected to exceed the low risk savings rate of 0.2%.
Growth vs Market Checks
  • China Resources Medical Holdings's earnings growth is positive but not above the Germany market average.
  • China Resources Medical Holdings's revenue growth is positive but not above the Germany market average.
Annual Growth Rates Comparison
Raw Data
DB:1PH Future Growth Rates Data Sources
Data Point Source Value (per year)
DB:1PH Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 7 Analysts 3.5%
DB:1PH Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 7 Analysts 4.1%
Germany Healthcare Industry Earnings Growth Rate Market Cap Weighted Average 9.1%
Germany Healthcare Industry Revenue Growth Rate Market Cap Weighted Average 5.9%
Germany Market Earnings Growth Rate Market Cap Weighted Average 13.1%
Germany Market Revenue Growth Rate Market Cap Weighted Average 4.9%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
DB:1PH Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (4 months ago) See Below
Future Estimates Average of up to 7 Analyst Estimates (S&P Global) See Below
All numbers in CNY Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
DB:1PH Future Estimates Data
Date (Data in CNY Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2023-12-31 2,553 530 499 1
2022-12-31 2,457 626 482 1
2021-12-31 2,175 487 462 4
2020-12-31 2,111 550 443 7
2019-12-31 1,958 625 407 7
DB:1PH Past Financials Data
Date (Data in CNY Millions) Revenue Cash Flow Net Income *
2018-12-31 2,059 334 431
2018-09-30 1,996 371 364
2018-06-30 1,932 407 298
2018-03-31 1,905 433 360
2017-12-31 1,878 460 421
2017-09-30 1,784 377 -446
2017-06-30 1,690 294 -1,312
2017-03-31 1,611 259 -1,410
2016-12-31 1,533 224 -1,507
2016-09-30 1,504 227 -656
2016-06-30 1,475 230 196
2016-03-31 1,424 231 181

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • China Resources Medical Holdings's earnings are expected to grow by 3.5% yearly, however this is not considered high growth (20% yearly).
  • China Resources Medical Holdings's revenue is expected to grow by 4.1% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
DB:1PH Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (4 months ago) See Below
Future Estimates Average of up to 7 Analyst Estimates (S&P Global) See Below

All data from China Resources Medical Holdings Company Filings, last reported 4 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:1PH Future Estimates Data
Date (Data in CNY Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2023-12-31 0.39 0.39 0.39 1.00
2022-12-31 0.37 0.37 0.37 1.00
2021-12-31 0.35 0.36 0.35 3.00
2020-12-31 0.34 0.40 0.29 6.00
2019-12-31 0.32 0.36 0.28 6.00
DB:1PH Past Financials Data
Date (Data in CNY Millions) EPS *
2018-12-31 0.34
2018-09-30 0.29
2018-06-30 0.23
2018-03-31 0.28
2017-12-31 0.33
2017-09-30 -0.37
2017-06-30 -1.16
2017-03-31 -1.39
2016-12-31 -1.67
2016-09-30 -0.76
2016-06-30 0.24
2016-03-31 0.22

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • China Resources Medical Holdings is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess China Resources Medical Holdings's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Germany market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Germany market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
China Resources Medical Holdings has a total score of 1/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has China Resources Medical Holdings performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare China Resources Medical Holdings's growth in the last year to its industry (Healthcare).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • China Resources Medical Holdings's year on year earnings growth rate was negative over the past 5 years, however the most recent earnings are above average.
  • China Resources Medical Holdings's 1-year earnings growth exceeds its 5-year average (2.3% vs -10.9%)
  • China Resources Medical Holdings's earnings growth has not exceeded the DE Healthcare industry average in the past year (2.3% vs 4.7%).
Earnings and Revenue History
China Resources Medical Holdings's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from China Resources Medical Holdings Company Filings, last reported 4 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:1PH Past Revenue, Cash Flow and Net Income Data
Date (Data in CNY Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 2,059.48 430.90 223.43
2018-09-30 1,995.60 364.50 225.03
2018-06-30 1,931.72 298.10 226.64
2018-03-31 1,904.72 359.57 219.15
2017-12-31 1,877.72 421.03 211.66
2017-09-30 1,783.74 -445.66 203.62
2017-06-30 1,689.75 -1,312.35 195.57
2017-03-31 1,611.29 -1,409.66 183.82
2016-12-31 1,532.83 -1,506.96 172.06
2016-09-30 1,504.02 -655.62 167.33
2016-06-30 1,475.20 195.73 162.60
2016-03-31 1,423.73 181.39 156.26
2015-12-31 1,372.27 167.05 149.92
2015-09-30 1,336.92 208.17 123.54
2015-06-30 1,301.56 249.29 97.16
2015-03-31 1,253.91 239.67 91.37
2014-12-31 1,206.27 230.05 85.59
2014-09-30 1,090.45 176.04 84.78
2014-06-30 974.63 122.02 83.98
2014-03-31 930.99 106.01 79.06
2013-12-31 887.35 89.99 74.13
2013-09-30 871.77 101.30 67.37
2013-06-30 856.18 112.62 60.61
2013-03-31 807.11 106.85 55.26
2012-12-31 758.03 101.09 49.91

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • China Resources Medical Holdings has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • China Resources Medical Holdings used its assets more efficiently than the DE Healthcare industry average last year based on Return on Assets.
  • China Resources Medical Holdings's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess China Resources Medical Holdings's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
China Resources Medical Holdings has a total score of 2/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is China Resources Medical Holdings's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up China Resources Medical Holdings's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • China Resources Medical Holdings is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • China Resources Medical Holdings's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of China Resources Medical Holdings's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 4.7x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from China Resources Medical Holdings Company Filings, last reported 4 months ago.

DB:1PH Past Debt and Equity Data
Date (Data in CNY Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 5,709.82 535.55 1,897.04
2018-09-30 5,709.82 535.55 1,897.04
2018-06-30 5,656.63 259.14 1,689.40
2018-03-31 5,656.63 259.14 1,689.40
2017-12-31 5,601.57 229.20 1,592.33
2017-09-30 5,601.57 229.20 1,592.33
2017-06-30 5,520.62 445.70 1,332.86
2017-03-31 5,520.62 445.70 1,332.86
2016-12-31 5,357.53 109.34 1,188.67
2016-09-30 5,357.53 109.34 1,188.67
2016-06-30 2,012.16 0.00 800.32
2016-03-31 2,012.16 0.00 800.32
2015-12-31 1,862.73 0.00 1,013.54
2015-09-30 1,862.73 0.00 1,013.54
2015-06-30 1,822.22 0.00 1,112.26
2015-03-31 1,822.22 0.00 1,112.26
2014-12-31 1,735.24 0.00 1,072.86
2014-09-30 1,735.24 0.00 1,072.86
2014-06-30 1,800.96 0.00 1,172.61
2014-03-31 1,800.96 0.00 1,172.61
2013-12-31 1,715.85 200.00 1,282.22
2013-09-30 1,715.85 200.00 1,282.22
2013-06-30 379.69 239.56 150.25
2013-03-31 379.69 239.56 150.25
2012-12-31 577.76 239.06 173.57
  • China Resources Medical Holdings's level of debt (9.4%) compared to net worth is satisfactory (less than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (11.5% vs 9.4% today).
  • Debt is well covered by operating cash flow (62.4%, greater than 20% of total debt).
  • China Resources Medical Holdings earns more interest than it pays, coverage of interest payments is not a concern.
X
Financial health checks
We assess China Resources Medical Holdings's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. China Resources Medical Holdings has a total score of 6/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is China Resources Medical Holdings's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
2.07%
Current annual income from China Resources Medical Holdings dividends. Estimated to be 1.93% next year.
If you bought €2,000 of China Resources Medical Holdings shares you are expected to receive €41 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • China Resources Medical Holdings's pays a higher dividend yield than the bottom 25% of dividend payers in Germany (1.45%).
  • China Resources Medical Holdings's dividend is below the markets top 25% of dividend payers in Germany (3.81%).
Upcoming dividend payment

Purchase China Resources Medical Holdings before the 'Buy Limit' to receive their next dividend payment.

Dividends are usually paid every 3 or 6 months, you can time your share purchase to take advantage of upcoming dividend payments.
Dividend payment calendar
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
DB:1PH Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 7 Analyst Estimates (S&P Global) See Below
Germany Healthcare Industry Average Dividend Yield Market Cap Weighted Average of 9 Stocks 1.6%
Germany Market Average Dividend Yield Market Cap Weighted Average of 326 Stocks 3.1%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.8%
Germany Bottom 25% Dividend Yield 25th Percentile 1.5%
Germany Top 25% Dividend Yield 75th Percentile 3.8%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

DB:1PH Future Dividends Estimate Data
Date (Data in CN¥) Dividend per Share (annual) Avg. No. Analysts
2023-12-31
2022-12-31
2021-12-31 0.10 1.00
2020-12-31 0.10 4.00
2019-12-31 0.09 3.00
DB:1PH Past Annualized Dividends Data
Date (Data in CN¥) Dividend per share (annual) Avg. Yield (%)
2019-04-26 0.102 2.106
2019-03-29 0.102 1.985
2018-04-26 0.089 1.564
2017-06-16 0.056 0.673
2015-12-17 0.000 0.000
2015-08-10 0.040 0.426
2015-05-13 0.040 0.359
2014-06-18 0.053 0.511

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • China Resources Medical Holdings has been paying a dividend for less than 10 years and during this time payments have been volatile (annual drop of over 20%).
  • Dividend payments have increased, but China Resources Medical Holdings only paid a dividend in the past 5 years.
Current Payout to shareholders
What portion of China Resources Medical Holdings's earnings are paid to the shareholders as a dividend.
  • Dividends paid are well covered by earnings (3.3x coverage).
Future Payout to shareholders
  • Dividends after 3 years are expected to be well covered by earnings (3.6x coverage).
X
Income/ dividend checks
We assess China Resources Medical Holdings's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can China Resources Medical Holdings afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. China Resources Medical Holdings has a total score of 3/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of China Resources Medical Holdings's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Libing Cheng
COMPENSATION CN¥3,458,000
AGE 54
TENURE AS CEO 0.8 years
CEO Bio

Mr. Libing Cheng serves as Vice President of Phoenix Healthcare Group Co. Ltd. Mr. Cheng served as an Executive General Manager at Phoenix Healthcare Group Co. Ltd. since March 2013. Mr. Cheng joined Phoenix Healthcare Group in September 2010 and is primarily responsible for daily operations of Phoenix Healthcare Group. He served as the Vice General Manager at Beijing Huaren Intech Hospital Management Consulting Co., Ltd., an investment and hospital management company, from 2006 to 2008 and the Vice General Manager for all of Beijing Huaren Intech Hospital Management Consulting Co., Ltd., Beijing Intech Eye Hospital Co., Ltd. and Intech Medical Chain from 2008 to 2010. From 1999 to 2002, he has served various positions at Beijing Kangchen Pharmaceutical Co., Ltd., including General Manager Assistant. He also worked as a Resident Doctor at Dongzhimen Hospital Affiliated to Beijing University of Traditional Chinese Medicine, a general traditional Chinese medicine hospital, from 1988 to 1998. He has been Chief Executive Officer of China Resources Phoenix Healthcare Holdings Company Limited since August 7, 2018 and serves as its Executive Director. Mr. Cheng received a Bachelor’s degree in Traditional Chinese Medicine from Beijing University of Traditional Chinese Medicine in Beijing in July 1988.

CEO Compensation
  • Libing's compensation has increased by more than 20% in the past year.
  • Libing's remuneration is lower than average for companies of similar size in Germany.
Management Team Tenure

Average tenure and age of the China Resources Medical Holdings management team in years:

1.2
Average Tenure
47.5
Average Age
  • The average tenure for the China Resources Medical Holdings management team is less than 2 years, this suggests a new team.
Management Team

Libing Cheng

TITLE
CEO, VP & Executive Director
COMPENSATION
CN¥3M
AGE
54
TENURE
0.8 yrs

Yuan Ren

TITLE
CFO & Executive Director
COMPENSATION
CN¥2M
AGE
45
TENURE
1.6 yrs

Zechang Xu

TITLE
Executive President
COMPENSATION
CN¥3M
AGE
56

Yanjun Fu

TITLE
Deputy GM & Executive Director
COMPENSATION
CN¥498K
AGE
38
TENURE
2.5 yrs

Yuewei Han

TITLE
Executive Director
COMPENSATION
CN¥2M
AGE
50

Qing Song

TITLE
Vice Chairman
AGE
53

Lin Du

TITLE
Chief General Counsel & Board Secretary
AGE
38

Yiu So

TITLE
Company Secretary
AGE
36
TENURE
0.8 yrs
Board of Directors Tenure

Average tenure and age of the China Resources Medical Holdings board of directors in years:

1.6
Average Tenure
53.5
Average Age
  • The average tenure for the China Resources Medical Holdings board of directors is less than 3 years, this suggests a new board.
Board of Directors

Anthony Wu

TITLE
Chairman
AGE
63
TENURE
0.8 yrs

Libing Cheng

TITLE
CEO, VP & Executive Director
COMPENSATION
CN¥3M
AGE
54
TENURE
3.3 yrs

Yuning Fu

TITLE
Honorary Chairman
AGE
61
TENURE
2.5 yrs

Yuan Ren

TITLE
CFO & Executive Director
COMPENSATION
CN¥2M
AGE
45
TENURE
1.6 yrs

Yanjun Fu

TITLE
Deputy GM & Executive Director
COMPENSATION
CN¥498K
AGE
38
TENURE
1.6 yrs

Yuewei Han

TITLE
Executive Director
COMPENSATION
CN¥2M
AGE
50
TENURE
1.6 yrs

Qing Song

TITLE
Vice Chairman
AGE
53
TENURE
0.8 yrs

Kwok Kwong

TITLE
Independent Non-Executive Director
COMPENSATION
CN¥433K
AGE
71
TENURE
5.7 yrs

Felix Lee

TITLE
Independent Non-Executive Director
COMPENSATION
CN¥240K
AGE
36
TENURE
3.8 yrs

Kathy Chiu

TITLE
Independent Non-Executive Director
AGE
69
TENURE
1.2 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
14. Mar 19 Sell Colonial First State Asset Management (Australia) Limited Company 13. Mar 19 13. Mar 19 -5,201,500 €0.61 €-3,176,926
08. Nov 18 Buy Colonial First State Asset Management (Australia) Limited Company 07. Nov 18 07. Nov 18 1,036,500 €0.64 €658,851
23. Oct 18 Sell Yanjun Fu Individual 16. Oct 18 16. Oct 18 -4,162 €0.67 €-2,792
23. Oct 18 Sell Libing Cheng Individual 16. Oct 18 16. Oct 18 -22,123 €0.67 €-14,840
16. Oct 18 Sell Wellington Management Group LLP Company 15. Oct 18 15. Oct 18 -359,000 €0.68 €-244,631
03. Oct 18 Buy Wellington Management Group LLP Company 02. Oct 18 02. Oct 18 307,768 €0.78 €239,405
02. Oct 18 Sell Wellington Management Group LLP Company 28. Sep 18 28. Sep 18 -418,494 €0.77 €-323,972
27. Sep 18 Sell Yanjun Fu Individual 24. Sep 18 24. Sep 18 -59,724 €0.76 €-45,614
27. Sep 18 Sell Libing Cheng Individual 24. Sep 18 24. Sep 18 -21,476 €0.76 €-16,402
04. Sep 18 Buy Colonial First State Asset Management (Australia) Limited Company 31. Aug 18 31. Aug 18 592,000 €0.79 €470,124
06. Jul 18 Buy Colonial First State Asset Management (Australia) Limited Company 04. Jul 18 04. Jul 18 1,644,000 €1.01 €1,658,139
X
Management checks
We assess China Resources Medical Holdings's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. China Resources Medical Holdings has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Description

China Resources Medical Holdings Company Limited, an investment holding company, provides general healthcare, and hospital management and consulting services in the People’s Republic of China. The company also engages in group purchasing organization business and other hospital-derived services. It also manages third party owned hospitals and clinics under the invest-operate-transfer (IOT) model. In addition, it is involved in supply chain business, including the sale of pharmaceuticals, medical devices, and medical consumables and equipment. The company was formerly known as China Resources Phoenix Healthcare Holdings Company Limited and changed its name to China Resources Medical Holdings Company Limited in October 2018. The company was founded in 2007 and is headquartered in Beijing, the People’s Republic of China.

Details
Name: China Resources Medical Holdings Company Limited
1PH
Exchange: DB
Founded: 2007
HK$827,361,074
1,296,676,516
Website: http://www.crphoenix.hk
Address: China Resources Medical Holdings Company Limited
E-825, No. 6 Taiping Street,
Xicheng District,
Beijing,
100050,
China
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
SEHK 1515 Ordinary Shares The Stock Exchange of Hong Kong Ltd. HK HKD 29. Nov 2013
OTCPK CRXX.F Ordinary Shares Pink Sheets LLC US USD 29. Nov 2013
DB 1PH Ordinary Shares Deutsche Boerse AG DE EUR 29. Nov 2013
SHSC 1515 Ordinary Shares Stock Exchange of Hong Kong Limited - Shanghai - Hong Kong Stock Connect HK HKD 29. Nov 2013
SZSC 1515 Ordinary Shares The Stock Exchange of Hong Kong - Shenzhen - Hong Kong Stock Connect HK HKD 29. Nov 2013
SEHK 1515 HKD0.00025 The Stock Exchange of Hong Kong Ltd. HK HKD 19. May 2019
Number of employees
Current staff
Staff numbers
1,120
China Resources Medical Holdings employees.
Industry
Health Care Facilities
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/05/19 22:26
End of day share price update: 2019/05/17 00:00
Last estimates confirmation: 2019/04/23
Last earnings filing: 2019/04/26
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.